Eli Lilly, the manufacturers of Prozac, assumed that anti-depressants couldn't sell in Japan. GlaxoSmithKline got rich proving them wrong.
Eli Lilly, the manufacturers of Prozac, assumed that anti-depressants couldn't sell in Japan. GlaxoSmithKline got rich proving them wrong.

It's a sad, sad world



Wesley Yang follows the western psychiatric establishment around the world, watching its representatives sometimes hurt the very people they try to help. Crazy Like Us: The Globalization of the American Psyche Ethan Watters Free Press Dh95 The history of western intervention abroad - well-meaning, overconfident, oblivious to cultural context, and therefore doomed to magnify and multiply the problems it has come to solve - gets a powerful new chapter in Ethan Watters's Crazy Like Us: The Globalization of the American Psyche. The book is a critical account of four western psychiatric interventions around the globe, and its heroes are a loose collection of researchers and anthropologists who dissent from the mental health orthodoxy that has spread from the United States to the rest of the planet.

The other doctors, aid workers, experts and executives Watters meets, by contrast, do not understand the cultures they have decided to educate and to heal - and they do not think they have to. As a result, they do not help the people they have come to help. Sometimes they hurt them. The westerners parachuting into foreign lands to promote various forms of "mental health literacy", as they call it, believe machines that can watch blood flow through the brain and drugs that can change the brain's chemistry have elevated modern psychiatry above the primitive diagnoses of the discipline's long infancy, when "culturally contrived manifestations of mental illness" ran riot.

During this age of blind empirical groping, doctors first identified symptoms like convulsive fits, paralysis and linguistic impediments as indicators of mental illness. But each time new diagnoses emerged in the medical literature, and in public discourse, doctors found that the incidence of these same symptoms skyrocketed. This shifting of the "symptom pool", as the medical historian Edward Shorter calls it, was a constant embarrassment to psychiatry's claim to provide timeless and objective descriptions of a hard reality.

But today, the new orthodoxy insists, western psychiatry is at last rooted in an objectively "biomedical" account of how the brain works and fails. The American Psychiatric Association's Diagnostic and Statistical Manual of Mental Illness is, on this view, a universally valid guidebook that describes "illnesses with a symptomatology and outcomes relatively unaffected by shifting cultural beliefs."

Not so, insists Watters. "All mental illnesses," he writes, " including such seemingly obvious categories such as depression, post-traumatic stress disorder, and even schizophrenia, are every bit as shaped and influenced by cultural beliefs and expectations as hysterical leg paralysis, or the vapours, or zar, or any other mental illness ever experienced in the history of human madness." All mental illnesses are cultural for the simple reason that all forms of expression are irreducibly cultural. The modern western individual for whom American psychiatric diagnoses were conceived is itself a cultural artefact - a radical break from conceptions of the self obtaining in the many non-western cultures where the individual is regarded "as inseparable from your role in your kinship group, intertwined the story of your ancestry and permeable to the spirit world". Thus any account of mental illness that uses a uniquely western template for all minds everywhere will inevitably "blind local clinicians to the unique realities of patients in different cultures".

Each of the four case studies that Watters examines poke holes in a different aspect of the western mental health orthodoxy. In Hong Kong, China's leading researcher of eating disorders finds that shifting cultural beliefs can radically alter the nature and distribution of a mental illness. In 1994, the highly publicised starvation death of a 14-year old schoolgirl - and the subsequent profileration of news reports containing the western definitions of an anorexia nervosa - led to a dramatic rise in the awareness, and the incidence, of the disease.

In Sri Lanka, thousands of Western-trained "trauma counsellors" marvelled at the obstinate cheerfulness and resilience of the natives in the wake of the 2004 tsunami that ravaged the island. They concluded that the Sri Lankans were "in denial" and needed to be forced to confront the trauma they have just experienced - lest the unprocessed terror seep into their unconscious to fester and manifest itself as post-traumatic stress disorder. Toward that end they employed a "debriefing" technique that, in 1996, the British Medical Journal had concluded was "ineffective and has adverse long term effects" - namely the instigation of the very symptoms it is intended to avert.

The first western psychiatrist in Tanzania was keen on weaning the natives away from superstitious beliefs in spirit possession that stigmatise the mentally ill. Here, as elsewhere, western psychiatry acted as a tireless promoter of the view that mentally ill people are afflicted by an illness like any other. The view is meant to reduce the stigma experienced by the mentally ill. But everywhere the idea has been accepted, the effect has been to increase public aversion to the sick, further isolating them from their communities.

By contrast, Tanzanian beliefs in spirit possession have the effect of keeping the schizophrenic within the social group. A western anthropologist marvels at the "amazing tolerance" and "passive acceptance of abnormal behaviour" that one Tanzanian family shows toward the mentally ill in their midst. In the West, where the allegedly enlightened and humane biomedical view dominates, schizophrenics experience fewer periods of remission and lower levels of functioning than they do in cultures that believe in ghosts.

Not even a disease as seemingly straightforward as depression is exempt from a remarkable degree of cultural determination. Japanese people have traditionally considered profound sadness to be a poetic ennobling emotion, not a disease to be banished with the aid of doctors and pills. For this reason Eli Lilly, the makers of Prozac, declined to enter the Japanese market. "Executives in the company believed that the Japanese people wouldn't want to accept the drug," observes Watters, "More precisely, they wouldn't want to accept the disease." Glaxo SmithKline, the makers of Paxil, did not give up so easily. A "mega-marketing campaign" successfully altered the traditional Japanese view of sadness and depression. By 2009, sales of Paxil in the country had reached $1 billion.

The researchers that Watters lionises correctly note that the importation of western psychiatric process smuggles in cultural assumptions that threaten to upset social balance. For example, therapists working in Sri Lanka after the tsunami urged reflection and "individual quests of introspection" onto Sri Lankans - who conceived of themselves as tightly woven into kinship networks in which the well-being of the individual is contingent on the well-being of the group, and the well-being of the group as contingent on collective avoidance of unconstrained speech.

In doing so, they "largely discredited the power of local healing practices, as well as resiliency, coping and survival strategies" in a way that "had the potential to continue, in a new form, the very cultural demolition that had caused the population its greatest distress." In the end, Watters concludes, "offering the latest western mental health theories in an attempt to ameliorate the psychological stress caused by globalization is not a solution; it is part of the problem."

Wesley Yang writes for Tablet Magazine and n+1.

Company%20profile
%3Cp%3E%3Cstrong%3EName%3A%3C%2Fstrong%3E%20Yabi%20by%20Souqalmal%C2%A0%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3EStarted%3A%20%3C%2Fstrong%3EMay%202022%2C%20launched%20June%202023%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3EFounder%3A%20%3C%2Fstrong%3EAmbareen%20Musa%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3EBased%3A%20%3C%2Fstrong%3EDubai%C2%A0%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3ESector%3A%20%3C%2Fstrong%3EFinTech%C2%A0%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3EInitial%20investment%3A%20u%3C%2Fstrong%3Endisclosed%20but%20soon%20to%20be%20announced%C2%A0%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3ENumber%20of%20staff%3A%20%3C%2Fstrong%3E12%C2%A0%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3EInvestment%20stage%3A%20%3C%2Fstrong%3Eseed%C2%A0%C2%A0%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3EInvestors%3A%20%3C%2Fstrong%3EShuaa%20Capital%3C%2Fp%3E%0A
Oppenheimer
%3Cp%3E%3Cstrong%3EDirector%3A%20%3C%2Fstrong%3EChristopher%20Nolan%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3EStars%3A%20%3C%2Fstrong%3ECillian%20Murphy%2C%20Emily%20Blunt%2C%20Robert%20Downey%20Jr%2C%20Florence%20Pugh%2C%20Matt%20Damon%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3ERating%3A%20%3C%2Fstrong%3E5%2F5%3Cbr%3E%3C%2Fp%3E%0A
UAE FIXTURES

October 18 – 7.30pm, UAE v Oman, Zayed Cricket Stadium, Abu Dhabi
October 19 – 7.30pm, UAE v Ireland, Zayed Cricket Stadium, Abu Dhabi
October 21 – 2.10pm, UAE v Hong Kong, Zayed Cricket Stadium, Abu Dhabi
October 22 – 2.10pm, UAE v Jersey, Zayed Cricket Stadium, Abu Dhabi
October 24 – 10am, UAE v Nigeria, Abu Dhabi Cricket Oval 1
October 27 – 7.30pm, UAE v Canada, Zayed Cricket Stadium, Abu Dhabi

October 29 – 2.10pm, Playoff 1 – A2 v B3; 7.30pm, Playoff 2 – A3 v B2, at Dubai International Stadium.
October 30 – 2.10pm, Playoff 3 – A4 v Loser of Play-off 1; 7.30pm, Playoff 4 – B4 v Loser of Play-off 2 at Dubai International Stadium

November 1 – 2.10pm, Semifinal 1 – B1 v Winner of Play-off 1; 7.30pm, Semifinal 2 – A1 v Winner of Play-off 2 at Dubai International Stadium
November 2 – 2.10pm, Third place Playoff – B1 v Winner of Play-off 1; 7.30pm, Final, at Dubai International Stadium

Mercer, the investment consulting arm of US services company Marsh & McLennan, expects its wealth division to at least double its assets under management (AUM) in the Middle East as wealth in the region continues to grow despite economic headwinds, a company official said.

Mercer Wealth, which globally has $160 billion in AUM, plans to boost its AUM in the region to $2-$3bn in the next 2-3 years from the present $1bn, said Yasir AbuShaban, a Dubai-based principal with Mercer Wealth.

Within the next two to three years, we are looking at reaching $2 to $3 billion as a conservative estimate and we do see an opportunity to do so,” said Mr AbuShaban.

Mercer does not directly make investments, but allocates clients’ money they have discretion to, to professional asset managers. They also provide advice to clients.

“We have buying power. We can negotiate on their (client’s) behalf with asset managers to provide them lower fees than they otherwise would have to get on their own,” he added.

Mercer Wealth’s clients include sovereign wealth funds, family offices, and insurance companies among others.

From its office in Dubai, Mercer also looks after Africa, India and Turkey, where they also see opportunity for growth.

Wealth creation in Middle East and Africa (MEA) grew 8.5 per cent to $8.1 trillion last year from $7.5tn in 2015, higher than last year’s global average of 6 per cent and the second-highest growth in a region after Asia-Pacific which grew 9.9 per cent, according to consultancy Boston Consulting Group (BCG). In the region, where wealth grew just 1.9 per cent in 2015 compared with 2014, a pickup in oil prices has helped in wealth generation.

BCG is forecasting MEA wealth will rise to $12tn by 2021, growing at an annual average of 8 per cent.

Drivers of wealth generation in the region will be split evenly between new wealth creation and growth of performance of existing assets, according to BCG.

Another general trend in the region is clients’ looking for a comprehensive approach to investing, according to Mr AbuShaban.

“Institutional investors or some of the families are seeing a slowdown in the available capital they have to invest and in that sense they are looking at optimizing the way they manage their portfolios and making sure they are not investing haphazardly and different parts of their investment are working together,” said Mr AbuShaban.

Some clients also have a higher appetite for risk, given the low interest-rate environment that does not provide enough yield for some institutional investors. These clients are keen to invest in illiquid assets, such as private equity and infrastructure.

“What we have seen is a desire for higher returns in what has been a low-return environment specifically in various fixed income or bonds,” he said.

“In this environment, we have seen a de facto increase in the risk that clients are taking in things like illiquid investments, private equity investments, infrastructure and private debt, those kind of investments were higher illiquidity results in incrementally higher returns.”

The Abu Dhabi Investment Authority, one of the largest sovereign wealth funds, said in its 2016 report that has gradually increased its exposure in direct private equity and private credit transactions, mainly in Asian markets and especially in China and India. The authority’s private equity department focused on structured equities owing to “their defensive characteristics.”

Zayed%20Centre%20for%20Research
%3Cp%3EThe%20Zayed%20Centre%20for%20Research%20is%20a%20partnership%20between%20Great%20Ormond%20Street%20Hospital%2C%20University%20College%20London%20and%20Great%20Ormond%20Street%20Hospital%20Children%E2%80%99s%20Charity%20and%20was%20made%20possible%20thanks%20to%20a%20generous%20%C2%A360%20million%20gift%20in%202014%20from%20Sheikha%20Fatima%20bint%20Mubarak%2C%20Chairwoman%20of%20the%20General%20Women's%20Union%2C%20President%20of%20the%20Supreme%20Council%20for%20Motherhood%20and%20Childhood%2C%20and%20Supreme%20Chairwoman%20of%20the%20Family%20Development%20Foundation.%3C%2Fp%3E%0A
The National's picks

4.35pm: Tilal Al Khalediah
5.10pm: Continous
5.45pm: Raging Torrent
6.20pm: West Acre
7pm: Flood Zone
7.40pm: Straight No Chaser
8.15pm: Romantic Warrior
8.50pm: Calandogan
9.30pm: Forever Young

Western Region Asia Cup Qualifier

Results

UAE beat Saudi Arabia by 12 runs

Kuwait beat Iran by eight wickets

Oman beat Maldives by 10 wickets

Bahrain beat Qatar by six wickets

Semi-finals

UAE v Qatar

Bahrain v Kuwait

 

The rules on fostering in the UAE

A foster couple or family must:

  • be Muslim, Emirati and be residing in the UAE
  • not be younger than 25 years old
  • not have been convicted of offences or crimes involving moral turpitude
  • be free of infectious diseases or psychological and mental disorders
  • have the ability to support its members and the foster child financially
  • undertake to treat and raise the child in a proper manner and take care of his or her health and well-being
  • A single, divorced or widowed Muslim Emirati female, residing in the UAE may apply to foster a child if she is at least 30 years old and able to support the child financially
What is hepatitis?

Hepatitis is an inflammation of the liver, which can lead to fibrosis (scarring), cirrhosis or liver cancer.

There are 5 main hepatitis viruses, referred to as types A, B, C, D and E.

Hepatitis C is mostly transmitted through exposure to infective blood. This can occur through blood transfusions, contaminated injections during medical procedures, and through injecting drugs. Sexual transmission is also possible, but is much less common.

People infected with hepatitis C experience few or no symptoms, meaning they can live with the virus for years without being diagnosed. This delay in treatment can increase the risk of significant liver damage.

There are an estimated 170 million carriers of Hepatitis C around the world.

The virus causes approximately 399,000 fatalities each year worldwide, according to WHO.